GFAP and central nervous system cancer: With the fiber-swap mutations [9] and the optimized glial fibrillary acidic protein promoter [18,28], the mutation truncating the i-leader open reading frame protein constitutes a new addition to our arsenal of validated modules for inclusion in new replicating glioma-targeted adenoviruses.